Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarka Pavlova

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Oncology|June 7, 2003
High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeastSarka Pavlova, Jiri Mayer, Hana Koukalova, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Detection and Functional Analysis of TP53 Mutations in CLLSarka Pavlova, Jana Smardova, Nikola Tom, et al.
Human Mutation|January 14, 2014
TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemiaJitka Malcikova, Sarka Pavlova, Katerina Stano Kozubik, et al.
Leukemia Research|January 12, 2020
PRIMA-1<sup>MET</sup> cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cellsZuzana Jaskova, Sarka Pavlova, Jitka Malcikova, et al.
Oncology Reports|March 11, 2004
Analysis of tumor suppressor p53 status in head and neck squamous cell carcinomaJana Smardova, Katerina Ksicova, Hana Binkova, et al.
BMC Bioinformatics|June 27, 2018
ToTem: a tool for variant calling pipeline optimizationNikola Tom, Ondrej Tom, Jitka Malcikova, et al.
Haematologica|September 17, 2013
Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clonesKarla Plevova, Hana Skuhrova Francova, Katerina Burckova, et al.
British Journal of Haematology|December 8, 2023
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patientsVeronika Navrkalova, Karla Plevova, Lenka Radova, et al.
Molecular Oncology|November 5, 2022
Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damageVeronika Mancikova, Michaela Pesova, Sarka Pavlova, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 4, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traitsLucie Curylova, Iva Staniczkova Zambo, Jakub Neradil, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Oncology|June 7, 2003
High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeastSarka Pavlova, Jiri Mayer, Hana Koukalova, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2018
Detection and Functional Analysis of TP53 Mutations in CLLSarka Pavlova, Jana Smardova, Nikola Tom, et al.
Human Mutation|January 14, 2014
TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemiaJitka Malcikova, Sarka Pavlova, Katerina Stano Kozubik, et al.
Leukemia Research|January 12, 2020
PRIMA-1<sup>MET</sup> cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cellsZuzana Jaskova, Sarka Pavlova, Jitka Malcikova, et al.
Oncology Reports|March 11, 2004
Analysis of tumor suppressor p53 status in head and neck squamous cell carcinomaJana Smardova, Katerina Ksicova, Hana Binkova, et al.
BMC Bioinformatics|June 27, 2018
ToTem: a tool for variant calling pipeline optimizationNikola Tom, Ondrej Tom, Jitka Malcikova, et al.
Haematologica|September 17, 2013
Multiple productive immunoglobulin heavy chain gene rearrangements in chronic lymphocytic leukemia are mostly derived from independent clonesKarla Plevova, Hana Skuhrova Francova, Katerina Burckova, et al.
British Journal of Haematology|December 8, 2023
Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment-naïve CLL patientsVeronika Navrkalova, Karla Plevova, Lenka Radova, et al.
Molecular Oncology|November 5, 2022
Distinct p53 phosphorylation patterns in chronic lymphocytic leukemia patients are reflected in the activation of circumjacent pathways upon DNA damageVeronika Mancikova, Michaela Pesova, Sarka Pavlova, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 4, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traitsLucie Curylova, Iva Staniczkova Zambo, Jakub Neradil, et al.
Pageof 3